Cellulite and Magnetic Resonance Imaging
Anatomy of Subcutaneous Structures in Areas With and Without Cellulite Depressions by Magnetic Resonance Imaging
1 other identifier
observational
30
0 countries
N/A
Brief Summary
The purpose of this study is to compare the anatomy of subcutaneous structures in areas with and without cellulite on the buttocks of same subjects with a non invasive technique, Magnetic Resonance Imaging.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jul 2008
Typical duration for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2008
CompletedFirst Posted
Study publicly available on registry
March 14, 2008
CompletedStudy Start
First participant enrolled
July 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2010
CompletedFebruary 26, 2015
February 1, 2015
5 months
March 11, 2008
February 24, 2015
Conditions
Outcome Measures
Primary Outcomes (1)
The presence and characteristics of the fibrous septa in areas with and without cellulite.
image from MRI
at baseline
Secondary Outcomes (1)
The characteristics of the subcutaneous tissue in areas with and without cellulite.
at baseline
Study Arms (1)
Observational
Eligibility Criteria
Females patients with cellulite on the buttocks.
You may qualify if:
- Written Informed Consent;
- Subjects agreeing to take part of all procedures of the study, after being fully informed on the objectives and nature of the investigations;
- Healthy female subjects over 18 years;
- Subjects presenting cellulite on the buttocks;
- Medical history and physical examination which, based on the investigator's opinion, do not prevent the patient from taking part in the study and use the product under investigation;
- Female subjects of childbearing age should present a negative urine pregnancy test and should be using an effective contraceptive method (3 months before the enrollment until the end of the study);
- Availability of the subject throughout the duration of the study (180 days);
- Subjects with sufficient schooling and awareness to enable them to cooperate to the degree required by this protocol.
You may not qualify if:
- Pregnant women or women intending to become pregnant during the study (next 3 months);
- Subjects participating in other clinical trials;
- Any condition that, in the opinion of the investigator, can compromise the evaluation of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Doris Hexsellead
Biospecimen
None retained
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Dr. Doris Hexsel and Brazilan Center for Studies in Dermatology
Study Record Dates
First Submitted
March 11, 2008
First Posted
March 14, 2008
Study Start
July 1, 2008
Primary Completion
December 1, 2008
Study Completion
December 1, 2010
Last Updated
February 26, 2015
Record last verified: 2015-02